ArticleCells2020

Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer.

Shiue-Wei Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.